Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other solid neoplasm 1

Conditions

Testicular Germ Cell Tumor 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1

Interventions

Radiotherapy 34Gemcitabine 24Docetaxel 24bicalutamide 23Goserelin 21Paclitaxel 19Cisplatin 19Doxorubicin 18Carboplatin 18Flutamide 17Leuprolide 16Radiotherapy, Conformal 13Etoposide 13Filgrastim 12Prednisone 11Gene Expression Profiling 11Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Vincristine 8Vinblastine 8Triptorelin Pamoate 8Magnetic Resonance Spectroscopy 8Cyclophosphamide 8Buserelin 8Androgen Antagonists 8Surgical Procedures, Operative 7Radiation 7Polymerase Chain Reaction 7Methotrexate 7Estramustine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × sabarubicin × Genitourinary × Clear all
NCT00027781 2012-07-24

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
37 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003982 2012-07-11

MEN-10755 in Treating Patients With Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
30 enrolled
Genitourinary

Testicular Germ Cell Tumor, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡